Group One Trading
KNSA icon

Group One Trading’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Group One Trading’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$169K Buy
+3,500
New +$155K ﹤0.01% 4266
2025
Q3 		– Sell
-400
Closed -$11.1K – 8771
2025
Q2 		$11.1K Buy
400
+100
+33% +$2.55K ﹤0.01% 6656
2025
Q1 		$6.66K Sell
300
-200
-40% -$4.12K ﹤0.01% 6503
2024
Q4 		$9.89K Hold
500
– – ﹤0.01% 6104
2024
Q3 		$12.5K Sell
500
-200
-29% -$4.87K ﹤0.01% 5497
2024
Q2 		$13.1K Buy
+700
New +$13.1K ﹤0.01% 5490
2024
Q1 		– Sell
-8,000
Closed -$140K – 7508
2023
Q4 		$140K Sell
8,000
-56,600
-88% -$930K ﹤0.01% 4180
2023
Q3 		$1.12M Buy
64,600
+2,500
+4% +$42.1K ﹤0.01% 2146
2023
Q2 		$874K Sell
62,100
-40,200
-39% -$538K ﹤0.01% 2482
2023
Q1 		$1.1M Buy
102,300
+300
+0.3% +$3.95K ﹤0.01% 2054
2022
Q4 		$1.53M Buy
102,000
+52,700
+107% +$767K ﹤0.01% 2061
2022
Q3 		$633K Sell
49,300
-21,600
-30% -$246K ﹤0.01% 3002
2022
Q2 		$687K Buy
70,900
+58,700
+481% +$548K ﹤0.01% 3133
2022
Q1 		$121K Sell
12,200
-25,300
-67% -$268K ﹤0.01% 5305
2021
Q4 		$441K Sell
37,500
-35,700
-49% -$439K ﹤0.01% 4272
2021
Q3 		$834K Buy
73,200
+65,000
+793% +$846K ﹤0.01% 3610
2021
Q2 		$114K Sell
8,200
-3,600
-31% -$54.7K ﹤0.01% 5826
2021
Q1 		$218K Buy
11,800
+6,700
+131% +$137K ﹤0.01% 4946
2020
Q4 		$90K Buy
+5,100
New +$89.6K ﹤0.01% 4649

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Group One Trading's KNSA Position: Q1 2026 in Review

Group One Trading sold out of Kiniksa Pharmaceuticals (KNSA) in Q1 2026, closing a stake of 200 shares — an estimated $8.86K sold.

Group One Trading first reported a position in KNSA in Q1 2021 and held it in 12 quarters. The position peaked at $312K in Q3 2021. 228 funds tracked by Wall St. Rank hold KNSA as of Q1 2026.

  • Group One Trading reported no remaining Kiniksa Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 200 Kiniksa Pharmaceuticals shares in Q1 2026, an estimated $8.86K.
  • Group One Trading first reported a position in Kiniksa Pharmaceuticals in Q1 2021 and held it in 12 quarters.
  • Group One Trading's Kiniksa Pharmaceuticals position peaked at $312K in Q3 2021.
  • 228 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.